Differentiation-Associated Reprogramming of the Transforming Growth Factor β Receptor Pathway Establishes the Circuitry for Epithelial Autocrine/Paracrine Repair

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Fleming, Jonathan M ^a   Shabir, Saqib ^a   Varley, Claire L ^a   Kirkwood, Lisa A ^a   White, Angela ^b   Holder, Julie ^b   Trejdosiewicz, Ludwik K ^a   Southgate, Jennifer ^a   Tang, Yao Liang ^c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PROTEIN FUNCTION; TISSUE DIFFERENTIATION; TISSUE REPAIR; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; UROTHELIUM;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; HELA CELLS; HOMEOSTASIS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARACRINE COMMUNICATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UROTHELIUM; WOUND HEALING;

EID: 84871341151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051404     Document Type: Article

References (28)

1. Hicks RM, (1975) The mammalian urinary bladder: an accommodating organ. Biol Rev Camb Philos Soc 50: 215-246.
2. Olsburgh J, Harnden P, Weeks R, Smith B, Joyce A, et al. (2003) Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. J Pathol 199: 41-49.
3. Sun TT, Liang FX, Wu XR, (1999) Uroplakins as markers of urothelial differentiation. Adv Exp Med Biol 462: 7-18; discussion 103-114.
4. Shin K, Lee J, Guo N, Kim J, Lim A, et al. (2011) Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472: 110-114.
5. Varley C, Hill G, Pellegrin S, Shaw NJ, Selby PJ, et al. (2005) Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp Cell Res 306: 216-229.
6. Heldin CH, Landstrom M, Moustakas A, (2009) Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21: 166-176.
7. Zi Z, Chapnick DA, Liu X, (2012) Dynamics of TGF-beta/Smad signaling. FEBS Lett 586: 1921-1928.
8. Sillett HK, Cruickshank SM, Southgate J, Trejdosiewicz LK, (2001) Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells. Immunology 102: 310-316.
9. Caja L, Kahata K, Moustakas A, (2012) Context-dependent action of transforming growth factor beta family members on normal and cancer stem cells. Curr Pharm Des.
10. Lobban ED, Smith BA, Hall GD, Harnden P, Roberts P, et al. (1998) Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 153: 1957-1967.
11. Cross WR, Eardley I, Leese HJ, Southgate J, (2005) A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function. Am J Physiol Renal Physiol 289: F459-468.
12. Varley CL, Garthwaite MA, Cross W, Hinley J, Trejdosiewicz LK, et al. (2006) PPARgamma-regulated tight junction development during human urothelial cytodifferentiation. J Cell Physiol 208: 407-417.
13. Varley CL, Stahlschmidt J, Lee WC, Holder J, Diggle C, et al. (2004a) Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J Cell Sci 117: 2029-2036.
14. Varley CL, Stahlschmidt J, Smith B, Stower M, Southgate J, (2004b) Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Am J Pathol 164: 1789-1798.
15. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK, (1994) Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 71: 583-594.
16. Southgate J, Masters JR, Trejdosiewicz LK (2002) Culture of Human Urothelium. In: Freshney RI, Freshney MG, editors. Culture of Epithelial Cells. 2nd edition ed. New York: J Wiley and Sons, Inc. pp. 381-400.
17. Zhang J, Ramesh N, Chen Y, Li Y, Dilley J, et al. (2002) Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel. Cancer Res 62: 3743-3750.
18. Walker DC, Hill G, Wood SM, Smallwood RH, Southgate J, (2004) Agent-based computational modeling of wounded epithelial cell monolayers. IEEE Trans Nanobioscience 3: 153-163.
19. Southgate J, Varley CL, Garthwaite MA, Hinley J, Marsh F, et al. (2007) Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int 99: 1506-1516.
20. Shinar DM, Rodan GA, (1990) Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 126: 3153-3158.
21. Bombara C, Ignotz RA, (1992) TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. J Cell Physiol 153: 30-37.
22. Massague J, (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
23. de Boer WI, Rebel JM, Vermey M, de Jong AA, van der Kwast TH, (1994) Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture. Exp Cell Res 214: 510-518.
24. Booth C, Harnden P, Selby PJ, Southgate J, (2002) Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder. J Pathol 198: 359-368.
25. Zavadil J, Bottinger EP, (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
26. Southgate J, Kennedy W, Hutton KA, Trejdosiewicz LK, (1995) Expression and in vitro regulation of integrins by normal human urothelial cells. Cell Adhes Commun 3: 231-242.
27. Hannon GJ, Beach D, (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
28. Herrera RE, Makela TP, Weinberg RA, (1996) TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol Biol Cell 7: 1335-1342.